Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.720
+0.070 (2.64%)
At close: Apr 2, 2026, 4:00 PM EDT
2.660
-0.060 (-2.21%)
After-hours: Apr 2, 2026, 7:11 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $249.91 million as of April 2, 2026. Its market cap has increased by 240.08% in one year.
Market Cap
249.91M
Enterprise Value
184.03M
1-Year Change
240.08%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $249.91M, an increase of 389.75%. That is a compound annual growth rate of 42.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 249.91M | 85.03% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alector | 265.97M |
| Editas Medicine | 261.32M |
| Cellectis | 260.21M |
| Sol-Gel Technologies | 259.75M |
| Coherus Oncology | 259.31M |
| ALX Oncology Holdings | 259.27M |
| Cybin | 256.18M |
| Orchestra BioMed Holdings | 249.88M |